Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field - Psychedelic Alpha In our latest Pα+ interview, our Editor Josh Hardman speaks with Javier Muniz, MD, who recently left his post as Associate Director at the FDA’s Division of Psychiatry. In that role, Muniz was at the…

Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field

@josh-hardman.bsky.social chats with Muniz, who recently left his post as Ass. Director @ FDA Division of Psychiatry, about all things psychedelics

psychedelicalpha.com/news/inside-...

Explore the map here:
psychedelicalpha.com/data/psyched...

Updated: The Psychedelic Legalization & Decriminalization Tracker, Now In Partnership with BCSP

UC Berkeley’s Center for the Science of Psychedelics joins @calyx.law as a partner on our U.S. psychedelic policy reform tracker.

Together, we will maintain this tool, which we first published in 2021.